| 000 | 01613 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517051907.0 | ||
| 264 | 0 | _c20161005 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.12778 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHan, Kelong | |
| 245 | 0 | 0 |
_aBevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJan 2016 |
||
| 300 |
_a148-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPeyret, Thomas | |
| 700 | 1 | _aQuartino, Angelica | |
| 700 | 1 | _aGosselin, Nathalie H | |
| 700 | 1 | _aGururangan, Sridharan | |
| 700 | 1 | _aCasanova, Michela | |
| 700 | 1 | _aMerks, Johannes H M | |
| 700 | 1 | _aMassimino, Maura | |
| 700 | 1 | _aGrill, Jacques | |
| 700 | 1 | _aDaw, Najat C | |
| 700 | 1 | _aNavid, Fariba | |
| 700 | 1 | _aJin, Jin | |
| 700 | 1 | _aAllison, David E | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 81 _gno. 1 _gp. 148-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.12778 _zAvailable from publisher's website |
| 999 |
_c25237246 _d25237246 |
||